Related Experiment Video
Updated: Jun 21, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Epstein-Barr virus in multiple sclerosis.
1Department of Neurology, 1542 Tulane Avenue, Room 718B, Louisiana State University Health Science Center, New Orleans, LA 70112, USA. bbager@lsuhsc.edu
Prior Epstein-Barr virus (EBV) infection is strongly linked to developing multiple sclerosis (MS). Most people get EBV, but 99% of MS patients show evidence of prior EBV infection, suggesting a necessary role.
Area of Science:
- Neuroimmunology
- Virology
- Epidemiology
Background:
- Epstein-Barr virus (EBV) infects over 90% of the global population, typically remaining latent.
- A high prevalence of prior EBV infection is observed in multiple sclerosis (MS) patients (99%) compared to the general population.
- EBV establishes lifelong infection in memory B lymphocytes, evading immune detection.
Purpose of the Study:
- To review the evidence linking Epstein-Barr virus (EBV) to the pathogenesis of multiple sclerosis (MS).
- To explore potential mechanisms by which EBV may contribute to MS development.
- To consider the therapeutic implications of the EBV-MS relationship.
Main Methods:
- Review of seroepidemiologic studies correlating EBV infection rates with MS.
- Analysis of pathologic findings in postmortem MS brain tissue.
- Examination of proposed pathogenetic theories including antigenic mimicry and B-cell dysregulation.
Main Results:
- Elevated EBV antibody titers are detected in MS patients years preceding neurological symptoms.
- Postmortem analyses reveal widespread EBV-associated B-cell abnormalities in all forms of MS.
- Strong correlation between prior EBV infection and MS development.
Conclusions:
- Prior Epstein-Barr virus infection is strongly suggested as a necessary factor in multiple sclerosis development.
- EBV-associated B-cell immortalization and immune dysregulation are key proposed mechanisms.
- Understanding the EBV-MS link offers potential avenues for novel MS therapies.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Related Concept Videos
Multiple Sclerosis l: Introduction
Arboviral Encephalitis
Encephalitis ll: Pathophysiology
Cytomegalovirus Disease
Encephalitis l: Introduction